農業用生物製剤市場規模、シェア、動向、2030年までの世界予測

Agricultural Biologicals Market - Global Forecast To 2030

Agricultural Biologicals Market by Type (Biocontrol, Biostimulants, Biofertilizers), Source (Microbials, Semiochemicals, Natural Products), Formulation, Mode of Application (Foliar Spray, Seed Treatment, Soil Treatment) - Global Forecast to 2030

商品番号 : SMB-12897

出版社MarketsandMarkets
出版年月2025年10月
ページ数397
図表数391
価格タイプシングルユーザライセンス
価格USD 4,950
種別英文調査報告書

農業用生物製剤市場 – タイプ(生物防除、生物刺激剤、生物肥料)、供給源(微生物、情報化学物質、天然物)、製剤、施用方法(葉面散布、種子処理、土壌処理) – 2030年までの世界予測

農業用生物製剤市場は、2025年には184億4,000万米ドルに達すると推定され、2030年には349億9,000万米ドルに達し、予測期間中に年平均成長率(CAGR)13.7%で成長すると予測されています。FiBLおよびIFOAM – Organics Internationalによると、有機農業は188か国で行われており、9,600万ヘクタール以上の農地が少なくとも450万人の農家によって有機的に管理されています。2022年には、オーガニック食品および飲料の世界的売上高は約1,420億米ドルに急上昇しました。この広範な受容と市場収益の大幅な成長は、持続可能な無農薬農業に対する消費者の強い選好を反映しており、農業用生物製剤市場に直接的な利益をもたらします。有機製品の需要が高まるにつれて、生物刺激剤、生物農薬、生物肥料などの天然で環境に優しい投入物の需要も高まり、この分野のイノベーションと拡大を促進します。

農業用生物製剤市場は、シンジェンタグループ(スイス)、BASF(ドイツ)、FMCコーポレーション(米国)、コルテバ(米国)、バイエルAG(ドイツ)、UPL(インド)といった主要企業が市場を席巻しています。これらの企業は、農業用生物製剤分野における新製品の発売とイノベーションに多額の投資を行っています。例えば、バイエルAGは2023年3月、作物の幅広い真菌性疾患を標的とする生物殺菌剤「セレナーデASO」を発売しました。これは、従来の化学殺菌剤に代わる効果的で持続可能な代替手段を農家に提供しています。FMCコーポレーションは2023年8月、枯草菌を配合した最先端の農薬「エンタジア」を発売し、持続可能な農業における大きな進歩を示しました。

本調査レポートは、農業用生物製剤市場を、タイプ(生物防除、生物刺激剤、生物肥料)、供給源(微生物、情報化学物質、天然物)、作物の種類(穀類・穀物、油糧種子・豆類、果物・野菜、その他の作物)、製剤(液体、乾燥)、施用方法(葉面散布、種子処理、土壌処理)、地域(北米、欧州、アジア太平洋、南米、その他)別に分類しています。本レポートは、農業用生物製剤市場の成長に影響を与える推進要因、制約要因、課題、機会に関する詳細な情報を網羅しています。

主要業界プレーヤーの詳細な分析を行い、事業概要、サービス、主要戦略、契約、パートナーシップ、合意、新サービスの開始、合併・買収、そして農業用バイオ医薬品市場に関連する最近の動向に関する洞察を提供しています。本レポートは、農業用バイオ医薬品市場エコシステムにおける新興スタートアップ企業の競合分析を網羅しています。さらに、本調査では、技術分析、エコシステムと市場のマッピング、特許および規制の状況など、業界固有のトレンドも網羅しています。

本レポートは、農業用生物製剤市場全体および各サブセグメントの収益数値の近似値に関する情報を提供し、市場リーダーおよび新規参入企業にとって有益な情報となります。また、ステークホルダーが競争環境を理解し、事業のポジショニングを改善し、適切な市場開拓戦略を策定するための洞察を深めるのに役立ちます。さらに、本レポートは、ステークホルダーが市場の動向を把握し、主要な市場牽引要因、制約要因、課題、そして機会に関する情報を提供する上でも役立ちます。

本レポートは、以下の点について洞察を提供します。

農業用生物製剤市場の成長に影響を与える主要な推進要因(高付加価値作物への高い需要)、制約要因(政府規制の多様化)、機会(有機農業における植物由来の農業用生物製剤の活用)、課題(耐性菌の発現)の分析

  • 新製品の発売/イノベーション:農業用生物製剤市場における研究開発活動と新製品の発売に関する詳細な洞察
  • 市場開発:収益性の高い市場に関する包括的な情報、様々な地域における農業用生物製剤市場の分析
  • 市場多様化:農業用生物製剤市場における新サービス、未開拓地域、最近の動向、投資に関する網羅的な情報
  • 競合評価:農業用生物製剤市場における主要企業(BASF(ドイツ)、シンジェンタ(スイス)、バイエルAG(ドイツ)、UPL(インド)、コルテバ(米国)、FMCコーポレーション(米国)など)の市場シェア、成長戦略、製品ラインナップ、ブランド/製品比較、製品フットプリントに関する詳細な評価

Report Description

The market for agricultural biologicals is estimated to be USD 18.44 billion in 2025 and is projected to reach USD 34.99 billion by 2030, at a CAGR of 13.7% during the forecast period. According to FiBL & IFOAM – Organics International, organic farming exists in 188 countries, with more than 96 million hectares of farmland managed organically by at least 4.5 million farmers. In 2022, global sales of organic food and beverages skyrocketed to almost USD 142.0 billion. This wide acceptance and high growth of market revenues reflect the strong consumer preference towards sustainable, chemical-free farming, which directly benefits the agricultural biologicals market. As demand for organic products grows, so does demand for natural, environmentally friendly inputs like biostimulants, biopesticides, and biofertilizers, promoting innovation and expansion in the sector.

農業用生物製剤市場規模、シェア、動向、2030年までの世界予測
Agricultural Biologicals Market – Global Forecast To 2030

Key players such as Syngenta Group (Switzerland), BASF (Germany), FMC Corporation (US), Corteva (US), Bayer AG (Germany), and UPL (India) dominate the agricultural biologicals market. These companies are investing substantially in product launches and innovations in the agricultural biologicals space. For instance, in March 2023, Bayer AG launched Serenade ASO, a biological fungicide that targets a wide range of fungal diseases in crops, offering farmers an effective and sustainable alternative to traditional chemical fungicides. FMC Corporation launched ENTAZIA biofungicide in August 2023, a cutting-edge crop protection product formulated with Bacillus subtilis, marking a significant advancement in sustainable agriculture.

農業用生物製剤市場規模、シェア、動向、2030年までの世界予測 - by type
Agricultural Biologicals Market – Global Forecast To 2030 – by type

“The biocontrol products dominated the agricultural biologicals market within the function segment”

According to the FAO, up to 40% of global crop production is lost annually due to plant pests and diseases. Plant diseases, such as coffee leaf rust and banana fusarium wilt, have an annual cost estimated at more than USD 220 billion to the global economy. In addition to this, invasive insects, such as desert locusts and red palm weevils, cause annual losses of at least USD 70 billion. These significant economic impacts highlight the need for effective pest management, thereby driving the growth of the biocontrol segment in the agricultural biologicals market, which is sustainable in nature. Biopesticides are a sustainable and environmentally friendly substitute for chemical pesticides, gaining popularity for combating pervasive threats.

“Within the crop type segment, the market for fruits & vegetables is expected to register the highest CAGR during the forecast period”

The growth is powered by increasing consumer demand for organically grown and sustainable food. According to the Organic Industry Survey 2022, organic fruits and vegetables accounted for 15% of the total product market in the US, generating over USD 21 billion in revenue for 2021, a 4.5% increase from the previous year. The produce category, which includes fruits and vegetables, was a big driver of this growth. In fact, categories such as dried beans, fruits, and vegetables grew 6% and 6.5%, respectively, year over year. This theme aligns with consumers’ growing interest in organic produce, driving demand for agricultural biologicals, including biostimulants, biopesticides, and biofertilizers.

農業用生物製剤市場規模、シェア、動向、2030年までの世界予測 - 地域
Agricultural Biologicals Market – Global Forecast To 2030 – region

“North America holds the largest market share and is expected to be the fastest-growing market during the forecast period”

Factors such as large areas of farmland in the US and Canada, established advanced agriculture practices, high investments in research and development, and well-framed regulatory frameworks to foster sustainable agriculture will continue to help the North American region dominate the market during the forecast period. These countries have established institutional mechanisms for integrating biopesticides and biofertilizers into their production systems. At its simplest, the trend is a commitment to reducing dependency on chemical pesticides and promoting sustainability in agriculture.

In the US, the market for agricultural biologicals is driven by federal policies such as the Organic Foods Production Act and state-level activities in organic and biological farming practices. Other factors driving the growth of the agricultural biologicals market include growing consumer demand for organic produce and the increasing adoption of IPM strategies. In Canada, proactive initiatives in the realm of sustainable agriculture and environmental care further promote the use of biological products. According to the FiBL & IFOAM – Organics International (2024), in 2023, organic farming across North America involved over 3.6 million hectares—2.06 million hectares in the US and 1.56 million hectares in Canada—accounting for 0.8 percent of this region’s agricultural land. This vigorous engagement in organic farming strengthens North America’s lead in the agricultural biologicals market.

Break-up of Primaries

In-depth interviews were conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the agricultural biologicals market:

  • By Company Type: Tier 1 – 25%, Tier 2 – 45%, and Tier 3 – 30%
  • By Designation: Directors– 20%, Managers – 50%, Executives – 30%
  • By Region: North America – 25%, Europe – 30%, Asia Pacific – 20%, South America – 15%, and Rest of the World – 10%

Prominent companies in the market include BASF SE (Germany), Syngenta Group (Switzerland), Bayer AG (Germany), FMC Corporation (US), Corteva (US), UPL (India), Nufarm (Australia), Novonesis (Denmark), Lallemand Inc. (Canada), Mosaic (US), Rovensa Next (Spain), Sumitomo Chemical Co., Ltd. (Japan), SEIPASA, S.A. (Spain), Koppert (Netherlands), and Gowan Company (US).

Other players include IPL Biologicals (India), Bioceres Crop Solutions (Argentina), Rovensa Next (Spain), Bionema (UK), BioConsortia (US), Certis USA L.L.C. (US), Futureco Bioscience (Spain), Gowan Company (US), AgriLife (India), and Andermatt Group AG (Switzerland).

農業用生物製剤市場規模、シェア、動向、2030年までの世界予測 - 対象企業
Agricultural Biologicals Market – Global Forecast To 2030 – ecosystem

Research Coverage

This research report categorizes the agricultural biologicals market by Type (Biocontrol, Biostimulants, Biofertilizers), Source (Microbials, Semiochemicals, Natural Products), Crop Type (Cereals & Grains, Oilseed & Pulses, Fruits & Vegetables, Other Crop Types), Formulation (Liquid, Dry), Mode of Application (Foliar Spray, Seed Treatment, Soil Treatment), and Region (North America, Europe, Asia Pacific, South America, and Rest of the World). The scope of the report covers detailed information regarding drivers, restraints, challenges, and opportunities influencing the growth of the agricultural biologicals market.

A detailed analysis of the key industry players was done to provide insights into their business overview, services, key strategies, contracts, partnerships, agreements, new service launches, mergers and acquisitions, and recent developments associated with the agricultural biologicals market. This report covers the competitive analysis of upcoming startups in the agricultural biologicals market ecosystem. Furthermore, the study also covers industry-specific trends, including technology analysis, ecosystem and market mapping, and patent and regulatory landscapes, among others.

Reasons to Buy this Report

The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall agricultural biologicals market and the subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

It provides insights into the following pointers:

Analysis of key drivers (high demand for high-value crops), restraints (varying government regulations), opportunities (use of plant-based agriculture biologicals in organic agriculture), and challenges (resistance development) influencing the growth of the agriculture biologicals market

  • New Product Launch/Innovation: Detailed insights into research & development activities and new product launches in the agriculture biologicals market
  • Market Development: Comprehensive information about lucrative markets – analysis of the agricultural biologicals market across varied regions
  • Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the agricultural biologicals market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparisons, and product footprints of leading players such as BASF (Germany), Syngenta (Switzerland), Bayer AG (Germany), UPL (India), Corteva (US), FMC Corporation (US), and others in the agricultural biologicals market

Table of Contents

1               INTRODUCTION              32

1.1           STUDY OBJECTIVES       32

1.1.1        MARKET DEFINITION   32

1.2           MARKET SCOPE                33

1.2.1        MARKET SEGMENTATION           33

1.2.2        INCLUSIONS AND EXCLUSIONS 34

1.3           YEARS CONSIDERED      35

1.4           UNIT CONSIDERED        35

1.4.1        CURRENCY/VALUE UNIT              35

1.4.2        VOLUME CONSIDERED 36

1.5           STAKEHOLDERS               36

1.6           SUMMARY OF CHANGES               37

2               RESEARCH METHODOLOGY       38

2.1           RESEARCH DATA              38

2.1.1        SECONDARY DATA          39

2.1.1.1    List of major secondary sources         39

2.1.1.2    Key data from secondary sources       39

2.1.2        PRIMARY DATA 40

2.1.2.1    Key data from primary sources           40

2.1.2.2    Key industry insights           41

2.1.2.3    Breakdown of primaries      42

2.2           MARKET SIZE ESTIMATION         42

2.2.1        BOTTOM-UP APPROACH              43

2.2.2        TOP-DOWN APPROACH                44

2.2.2.1    Approach to estimate market size using top-down analysis                 44

2.3           DATA TRIANGULATION                45

2.4           RESEARCH ASSUMPTIONS           46

2.5           RESEARCH LIMITATIONS AND RISK ASSESSMENT                 47

3               EXECUTIVE SUMMARY  48

4               PREMIUM INSIGHTS       53

4.1           ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN AGRICULTURAL BIOLOGICALS MARKET               53

4.2           NORTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE AND COUNTRY           54

4.3           AGRICULTURAL BIOLOGICALS MARKETS, BY COUNTRY                 54

4.4           AGRICULTURAL BIOLOGICALS MARKET, BY TYPE AND REGION                55

4.5           AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE AND REGION     56

4.6           AGRICULTURAL BIOLOGICALS MARKET, BY FORMULATION AND REGION    57

4.7           AGRICULTURAL BIOLOGICALS MARKET, BY MODE OF APPLICATION AND REGION       58

4.8           AGRICULTURAL BIOLOGICALS MARKET, BY CROP TYPE AND REGION     59

5               MARKET OVERVIEW       60

5.1           INTRODUCTION              60

5.2           MACROECONOMIC OUTLOOK  60

5.2.1        INCREASE IN FARM EXPENDITURES        60

5.2.1.1    Growth of organic farmland globally 61

5.2.2        INCREASE IN GLOBAL POPULATION      62

5.3           MARKET DYNAMICS       63

5.3.1        DRIVERS               64

5.3.1.1    Regulatory pressures and harmful effects associated with synthetic plant protection products   64

5.3.1.2    Increase in organic food sales             65

5.3.1.3    Growing environmental concerns      66

5.3.1.4    Technological innovations in biotechnology    67

5.3.2        RESTRAINTS      67

5.3.2.1    Technological and environmental constraints regarding use of biologicals              67

5.3.2.2    Absence of well-constructed marketing routes and surrounding infrastructure        68

5.3.2.3    Intense competition from established chemical fertilizers and pesticides               69

5.3.2.4    Competition from conventional solutions        69

5.3.3        OPPORTUNITIES              70

5.3.3.1    Advancements in microbial research across regions       70

5.3.3.2    Significant opportunity in Asia Pacific for agricultural biologicals manufacturers       70

5.3.3.3    Emerging biotechnological techniques enhancing product effectiveness          71

5.3.4        CHALLENGES    71

5.3.4.1    High preference for agrochemicals across developing regions                 71

5.3.4.2    Lack of technical skills in using biological products        72

5.3.4.3    Shelf-life and storage issues                72

5.4           IMPACT OF AI/GEN AI ON AGRICULTURAL BIOLOGICALS MARKET 73

5.4.1        INTRODUCTION              73

5.4.2        USE OF GENERATIVE AI IN AGRICULTURAL BIOLOGICALS   74

5.4.3        CASE STUDY ANALYSIS FOR IMPACT OF AI/GEN AI                 75

5.4.3.1    AI-driven innovation in biostimulants by ICL and Lavie Bio                 75

5.4.3.2    Koppert’s digital assistant revolutionizing crop protection in agricultural microbials market            75

5.4.3.3    OPTIMIZING RICE PRODUCTION WITH ECOSTIM BIOSTIMULANTS             76

6               INDUSTRY TRENDS         77

6.1           INTRODUCTION              77

6.2           IMPACT OF 2025 US TARIFF – AGRICULTURAL BIOLOGICALS MARKET 77

6.2.1        INTRODUCTION              77

6.2.2        KEY TARIFF RATES          78

6.2.3        PRICE IMPACT ANALYSIS             78

6.2.4        IMPACT ON COUNTRY/REGION                79

6.2.4.1    US           79

6.2.4.2    Europe   79

6.2.4.3    Asia Pacific            79

6.2.5        IMPACT ON END-USE INDUSTRIES          79

6.3           VALUE CHAIN ANALYSIS               80

6.3.1        RESEARCH & PRODUCT DEVELOPMENT               80

6.3.2        RAW MATERIAL SOURCING         80

6.3.3        PRODUCTION   81

6.3.4        FORMULATION 81

6.3.5        DISTRIBUTION 81

6.3.6        END-USE APPLICATION                81

6.4           TRADE ANALYSIS             81

6.4.1        EXPORT SCENARIO OF HS CODE 3808     81

6.4.2        IMPORT SCENARIO OF HS CODE 3808     83

6.5           TECHNOLOGY ANALYSIS             84

6.5.1        KEY TECHNOLOGIES     84

6.5.1.1    RNAi-based biopesticides   84

6.5.2        COMPLEMENTARY TECHNOLOGIES       85

6.5.2.1    Precision agriculture tools  85

6.5.3        ADJACENT TECHNOLOGIES       85

6.5.3.1    Biodegradable polymer coatings        85

6.6           PRICING ANALYSIS          85

6.6.1        AVERAGE SELLING PRICE OF AGRICULTURAL BIOLOGICAL TYPES, BY KEY PLAYER, 2024            86

6.6.2        AVERAGE SELLING PRICE OF AGRICULTURAL BIOLOGICAL TYPES, BY KEY PLAYER, 2024            86

6.6.3        AVERAGE SELLING PRICE TREND OF AGRICULTURAL BIOLOGICALS, BY TYPE, 2020–2024 (USD/KG)     87

6.6.4        AVERAGE SELLING PRICE TREND OF AGRICULTURAL BIOLOGICALS, BY TYPE, 2020–2024            87

6.6.5        AVERAGE SELLING PRICE TREND OF AGRICULTURAL BIOLOGICAL PRODUCTS, BY REGION, 2020–2024                88

6.6.6        AVERAGE SELLING PRICE TREND OF AGRICULTURAL BIOLOGICAL PRODUCTS, BY REGION, 2020–2024                88

6.7           ECOSYSTEM ANALYSIS  89

6.7.1        DEMAND SIDE  89

6.7.2        SUPPLY SIDE     89

6.8           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            91

6.9           PATENT ANALYSIS          92

6.10         KEY CONFERENCES AND EVENTS, 2025–2026        96

6.11         REGULATORY LANDSCAPE         96

6.11.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             97

6.11.2      US           99

6.11.3      CANADA               100

6.11.4      EUROPE               102

6.11.5      ASIA PACIFIC     103

6.11.5.1  India       104

6.11.5.2  Australia 104

6.11.5.3  Japan      105

6.11.6      SOUTH AMERICA             105

6.11.6.1  Brazil      106

6.11.6.2  Argentina               106

6.11.7      REST OF THE WORLD    106

6.12         PORTER’S FIVE FORCES ANALYSIS           107

6.12.1      INTENSITY OF COMPETITIVE RIVALRY 108

6.12.2      THREAT OF SUBSTITUTES          109

6.12.3      BARGAINING POWER OF BUYERS             109

6.12.4      BARGAINING POWER OF SUPPLIERS       109

6.12.5      THREAT OF NEW ENTRANTS      109

6.13         KEY STAKEHOLDERS AND BUYING CRITERIA     109

6.13.1      KEY STAKEHOLDERS IN BUYING PROCESS           109

6.13.2      BUYING CRITERIA           111

6.14         INVESTMENT AND FUNDING SCENARIO               112

6.15         CASE STUDY ANALYSIS 113

6.15.1      LAUNCH OF VOTIVO PRIME BY BASF FOR EFFECTIVE NEMATODE MANAGEMENT       113

6.15.2      LAUNCH OF NETURE BY SYNGENTA FOR ECO-FRIENDLY CROP PROTECTION 113

6.15.3      LAUNCH OF SOFERO FALL BY FMC CORPORATION TO COMBAT RESISTANT FALL ARMYWORM                114

7               AGRICULTURAL BIOLOGICALS MARKET, BY TYPE                 115

7.1           INTRODUCTION              116

7.2           BIOCONTROL   118

7.2.1        INCREASING USE OF BIOCONTROL METHODS IN INTEGRATED PEST MANAGEMENT TO DRIVE MARKET 118

7.2.2        BIOPESTICIDES 120

7.2.3        SEMIOCHEMICALS          120

7.3           BIOFERTILIZERS              122

7.3.1        NEED TO ENHANCE SOIL FERTILITY, CROP PRODUCTIVITY, AND TOLERANCE TO FUEL DEMAND FOR BIOFERTILIZERS              122

7.3.2        NITROGEN-FIXING BIOFERTILIZERS      125

7.3.3        PHOSPHATE-SOLUBILIZING & MOBILIZING BIOFERTILIZERS              125

7.3.4        POTASSIUM SOLUBILIZING & MOBILIZING BIOFERTILIZERS              125

7.3.5        OTHER BIOFERTILIZERS              126

7.4           BIOSTIMULANTS             126

7.4.1        NEED FOR PRECISION AGRICULTURE FOR OPTIMAL CROP ESTABLISHMENT AND ROOT GROWTH TO PROPEL MARKET               126

7.4.2        HUMIC SUBSTANCES     129

7.4.3        SEAWEED EXTRACTS     129

7.4.4        AMINO ACIDS   129

7.4.5        MICROBIAL AMENDMENTS         130

7.4.6        MINERALS & VITAMINS 130

7.4.7        OTHER BIOSTIMULANTS             130

8               AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE                 131

8.1           INTRODUCTION              132

8.2           MICROBIALS      133

8.2.1        FOCUS ON ENHANCING SOIL NUTRIENT AND PLANT YIELD TO BOOST DEMAND        133

8.2.2        BACTERIA           134

8.2.3        FUNGI  134

8.2.4        VIRUS    134

8.2.5        PROTOZOA        134

8.3           NATURAL PRODUCTS   136

8.3.1        NEED FOR ECO-FRIENDLY ALTERNATIVE TO TRADITIONAL PESTICIDES TO BOOST DEMAND              136

8.3.2        PLANT EXTRACTS            138

8.3.3        ORGANIC ACIDS & OTHERS         138

8.4           MACROBIALS     139

8.4.1        FOCUS ON ENHANCING BIODIVERSITY AND ECOLOGICAL BALANCE TO DRIVE DEMAND      139

8.5           SEMIOCHEMICALS          140

8.5.1        NEED FOR PRECISE AND EFFICIENT POST-HARVEST PEST MANAGEMENT TO ACCELERATE DEMAND              140

8.5.2        PHEROMONES  142

8.5.3        ALLELOCHEMICALS       142

9               AGRICULTURAL BIOLOGICALS MARKET, BY FORMULATION 143

9.1           INTRODUCTION              144

9.2           LIQUID 145

9.2.1        FOCUS ON ENHANCING CROP GROWTH AND HEALTH TO BOOST DEMAND      145

9.3           DRY        146

9.3.1        NEED FOR OPTIMAL CROP PERFORMANCE TO DRIVE DEMAND             146

10            AGRICULTURAL BIOLOGICALS MARKET, BY MODE OF APPLICATION   148

10.1         INTRODUCTION              149

10.2         FOLIAR SPRAY   150

10.2.1      NEED FOR RAPID ABSORPTION OF NUTRIENTS AND BIOACTIVE COMPOUNDS FOR PROTECTION AGAINST FOLIAR DISEASES AND PESTS TO DRIVE DEMAND           150

10.3         SEED TREATMENT          152

10.3.1      NEED FOR ENVIRONMENT-FRIENDLY ALTERNATIVE TO TRADITIONAL PESTICIDES TO BOOST DEMAND      152

10.4         SOIL TREATMENT           153

10.4.1      NEED TO ENHANCE PH LEVELS AND SOIL NUTRIENT QUALITY TO INCREASE DEMAND            153

10.5         OTHER MODES OF APPLICATION            154

11            AGRICULTURAL BIOLOGICALS MARKET, BY CROP TYPE                 156

11.1         INTRODUCTION              157

11.2         CEREALS & GRAINS         158

11.2.1      RISING DEMAND FOR ORGANIC CEREALS & GRAINS TO BOOST MARKET               158

11.2.2      RICE       160

11.2.3      WHEAT 160

11.2.4      CORN    160

11.2.5      OTHER CEREALS & GRAINS         161

11.3         OILSEEDS & PULSES       161

11.3.1      GROWING CULTIVATION OF OILSEEDS & PULSES TO DRIVE MARKET 161

11.3.2      SUNFLOWER      163

11.3.3      SOYBEAN             163

11.3.4      OTHER OILSEEDS & PULSES       163

11.4         FRUITS & VEGETABLES 164

11.4.1      RISING EXPORT OF FRUITS & VEGETABLES TO DRIVE MARKET               164

11.4.2      POME FRUITS    167

11.4.3      CITRUS FRUITS 167

11.4.4      ROOT & TUBER VEGETABLES    167

11.4.5      LEAFY VEGETABLES       168

11.4.6      BERRIES               168

11.4.7      OTHER FRUITS & VEGETABLES 168

11.5         OTHER CROP TYPES      169

12            AGRICULTURAL BIOLOGICALS MARKET, BY REGION                 171

12.1         INTRODUCTION              172

12.2         NORTH AMERICA             175

12.2.1      US           181

12.2.1.1  Favorable regulatory frameworks to enable convenient registration of biocontrol to propel market      181

12.2.2      CANADA               182

12.2.2.1  Government initiatives to promote integrated pest management practices to drive market     182

12.2.3      MEXICO                184

12.2.3.1  Flexibility in sowing practices, ample organic land, and strict regulatory compliance to boost market             184

12.3         EUROPE               186

12.3.1      GERMANY           192

12.3.1.1  Need for effective and sustainable inputs supporting organic farming practices and enhancing crop yields to drive market        192

12.3.2      FRANCE                193

12.3.2.1  Favorable regulatory environment and strategic developments from key companies to foster market growth   193

12.3.3      SPAIN    194

12.3.3.1  Significant contributions from SMEs and growing adoption of advanced technologies in farming to boost market         194

12.3.4      ITALY    196

12.3.4.1  Rising focus on IPM, implementation of pollution tax, and product launches by key vendors to propel market         196

12.3.5      UK          197

12.3.5.1  Presence of seaweed-based biofertilizers and implementation of Biopesticides Scheme to drive market               197

12.3.6      REST OF EUROPE             199

12.4         ASIA PACIFIC     200

12.4.1      CHINA  205

12.4.1.1  Pesticide reduction policies and development of advanced seaweed extraction technology to boost market               205

12.4.2      JAPAN   207

12.4.2.1  Focus on reducing chemical fertilizer use and mitigating environmental impacts to drive market             207

12.4.3      INDIA    208

12.4.3.1  Favorable government regulations to drive market for biocontrol, biofertilizers, and biopesticides          208

12.4.4      AUSTRALIA         211

12.4.4.1  Presence of organic farmland to bolster market growth 211

12.4.5      REST OF ASIA PACIFIC   212

12.5         SOUTH AMERICA             213

12.5.1      BRAZIL 218

12.5.1.1  Strategic government programs and substantial private sector investments to foster market growth 218

12.5.2      ARGENTINA       220

12.5.2.1  Rising demand for environment-friendly agricultural inputs and favorable regulatory framework to boost market             220

12.5.3      REST OF SOUTH AMERICA           221

12.6         REST OF THE WORLD    222

12.6.1      AFRICA 227

12.6.1.1  Transition toward sustainable agriculture through regional knowledge centers to fuel market      227

12.6.2      MIDDLE EAST   229

12.6.2.1  Rising demand for organic farming to drive market       229

13            COMPETITIVE LANDSCAPE         231

13.1         OVERVIEW          231

13.2         KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2025                 231

13.3         REVENUE ANALYSIS, 2020–2024  234

13.4         MARKET SHARE ANALYSIS, 2024                 235

13.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 238

13.5.1      STARS   238

13.5.2      EMERGING LEADERS     238

13.5.3      PERVASIVE PLAYERS      238

13.5.4      PARTICIPANTS 238

13.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         240

13.5.5.1  Company footprint               240

13.5.5.2  Region footprint   241

13.5.5.3  Type footprint       242

13.5.5.4  Source footprint    243

13.5.5.5  Formulation footprint          243

13.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        244

13.6.1      PROGRESSIVE COMPANIES         244

13.6.2      RESPONSIVE COMPANIES            244

13.6.3      DYNAMIC COMPANIES  244

13.6.4      STARTING BLOCKS         244

13.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 246

13.6.5.1  Detailed list of key startups/SMEs    246

13.6.5.2  Competitive benchmarking of key startups/SMEs          247

13.7         COMPANY VALUATION AND FINANCIAL METRICS                 248

13.8         BRAND/PRODUCT COMPARISON             249

13.9         COMPETITIVE SCENARIO             250

13.9.1      PRODUCT LAUNCHES   250

13.9.2      DEALS  258

13.9.3      EXPANSIONS     270

14            COMPANY PROFILES      274

14.1         KEY PLAYERS     274

14.1.1      BASF SE                 274

14.1.1.1  Business overview 274

14.1.1.2  Products offered   275

14.1.1.3  Recent developments           277

14.1.1.3.1                Product launches and approvals         277

14.1.1.3.2                Deals      277

14.1.1.3.3                Expansions             280

14.1.1.4  MnM view              280

14.1.1.4.1                Right to win           280

14.1.1.4.2                Strategic choices made        280

14.1.1.4.3                Weaknesses and competitive threats 281

14.1.2      SYNGENTA         282

14.1.2.1  Business overview 282

14.1.2.2  Products offered   283

14.1.2.3  Recent developments           287

14.1.2.3.1                Product launches and approvals         287

14.1.2.3.2                Deals      288

14.1.2.3.3                Expansions             293

14.1.2.4  MnM view              295

14.1.2.4.1                Right to win           295

14.1.2.4.2                Strategic choices made        295

14.1.2.4.3                Weaknesses and competitive threats 295

14.1.3      FMC CORPORATION      296

14.1.3.1  Business overview 296

14.1.3.2  Products offered   297

14.1.3.3  Recent developments           298

14.1.3.3.1                Product launches and approvals         298

14.1.3.3.2                Deals      299

14.1.3.3.3                Other developments             301

14.1.3.4  MnM view              301

14.1.3.4.1                Right to win           301

14.1.3.4.2                Strategic choices made        301

14.1.3.4.3                Weaknesses and competitive threats 301

14.1.4      UPL        302

14.1.4.1  Business overview 302

14.1.4.2  Products offered   303

14.1.4.3  Recent developments           305

14.1.4.3.1                Product launches and approvals         305

14.1.4.3.2                Deals      307

14.1.4.4  MnM view              308

14.1.4.4.1                Right to win           308

14.1.4.4.2                Strategic choices made        308

14.1.4.4.3                Weaknesses and competitive threats 308

14.1.5      BAYER AG            309

14.1.5.1  Business overview 309

14.1.5.2  Products offered   310

14.1.5.3  Recent developments           311

14.1.5.3.1                Product launches and approvals         311

14.1.5.3.2                Deals      312

14.1.5.3.3                Expansions             314

14.1.5.4  MnM view              315

14.1.5.4.1                Right to win           315

14.1.5.4.2                Strategic choices made        315

14.1.5.4.3                Weaknesses and competitive threats 315

14.1.6      CORTEVA            316

14.1.6.1  Business overview 316

14.1.6.2  Products offered   317

14.1.6.3  Recent developments           318

14.1.6.3.1                Product launches and approvals         318

14.1.6.3.2                Deals      319

14.1.6.4  MnM view              323

14.1.6.4.1                Right to win           323

14.1.6.4.2                Strategic choices made        324

14.1.6.4.3                Weaknesses and competitive threats 324

14.1.7      BIOFIRST GROUP             325

14.1.7.1  Business overview 325

14.1.7.2  Products offered   325

14.1.7.3  Recent developments           326

14.1.7.3.1                Product launches and approvals         326

14.1.7.3.2                Deals      327

14.1.7.3.3                Expansions             329

14.1.8      LALLEMAND INC.             330

14.1.8.1  Business overview 330

14.1.8.2  Products offered   331

14.1.8.3  Recent developments           332

14.1.8.3.1                Product launches and approvals         332

14.1.8.4  MnM view              332

14.1.9      NUFARM              333

14.1.9.1  Business overview 333

14.1.9.2  Products offered   334

14.1.9.3  Recent developments           335

14.1.9.3.1                Product launches and approvals         335

14.1.9.3.2                Deals      336

14.1.9.3.3                Other developments             336

14.1.9.4  MnM view              336

14.1.10   MOSAIC                337

14.1.10.1                 Business overview 337

14.1.10.2                 Products offered   338

14.1.10.3                 Recent developments           339

14.1.10.3.1             Product launches and approvals         339

14.1.10.3.2             Deals      339

14.1.10.4                 MnM view              340

14.1.11   SUMITOMO CHEMICAL CO., LTD.             341

14.1.11.1                 Business overview 341

14.1.11.2                 Products offered   342

14.1.11.3                 Recent developments           344

14.1.11.3.1             Product launches and approvals         344

14.1.11.3.2             Deals      344

14.1.11.3.3             Expansions             345

14.1.11.4                 MnM view              346

14.1.12   INDIGO AG, INC.               347

14.1.12.1                 Business overview 347

14.1.12.2                 Products offered   347

14.1.12.3                 Recent developments           348

14.1.12.3.1             Product launches and approvals         348

14.1.12.3.2             Deals      348

14.1.12.4                 MnM view              348

14.1.13   NOVONESIS GROUP        349

14.1.13.1                 Business overview 349

14.1.13.2                 Products offered   350

14.1.13.3                 Recent developments           351

14.1.13.3.1             Product launches and approvals         351

14.1.13.3.2             Deals      352

14.1.13.4                 MnM view              353

14.1.14   BIOCERES CROP SOLUTIONS     354

14.1.14.1                 Business overview 354

14.1.14.2                 Products offered   355

14.1.14.3                 Recent developments           356

14.1.14.3.1             Product launches and approvals         356

14.1.14.3.2             Deals      357

14.1.14.4                 MnM view              358

14.1.15   KOPPERT             359

14.1.15.1                 Business overview 359

14.1.15.2                 Products offered   359

14.1.15.3                 Recent developments           360

14.1.15.3.1             Product launches and approvals         360

14.1.15.3.2             Deals      361

14.1.15.3.3             Expansions             364

14.1.15.4                 MnM view              364

14.2         OTHER PLAYERS              365

14.2.1      ROVENSA NEXT                365

14.2.1.1  Business overview 365

14.2.1.2  Products offered   365

14.2.1.3  Recent developments           366

14.2.1.3.1                Product launches and approvals         366

14.2.1.3.2                Deals      367

14.2.1.3.3                Expansions             367

14.2.2      MERISTEM CROP PERFORMANCE GROUP LLC   368

14.2.2.1  Business overview 368

14.2.2.2  Products offered   368

14.2.2.3  MnM view              368

14.2.3      SUSTAINABLE AGRO SOLUTIONS, S.A.U.               369

14.2.3.1  Business overview 369

14.2.3.2  Products offered   369

14.2.3.3  Recent developments           371

14.2.3.3.1                Deals      371

14.2.4      CERTIS USA L.L.C.            372

14.2.4.1  Business overview 372

14.2.4.2  Products offered   372

14.2.4.3  Recent developments           374

14.2.4.3.1                Product launches and approvals         374

14.2.4.3.2                Deals      375

14.2.4.3.3                Other developments             376

14.2.5      BIONEMA            377

14.2.5.1  Business overview 377

14.2.5.2  Products offered   377

14.2.5.3  Recent developments           378

14.2.5.3.1                Product launches and approvals         378

14.2.5.3.2                Deals      379

14.2.6      ANDERMATT GROUP AG              380

14.2.7      BIOCONSORTIA                381

14.2.8      APHEA.BIO         382

14.2.9      GÊNICA                383

14.2.10   NORDIC MICROBES A/S 384

15            ADJACENT AND RELATED MARKETS      385

15.1         INTRODUCTION              385

15.2         LIMITATIONS    385

15.3         BIOPESTICIDES MARKET              386

15.3.1      MARKET DEFINITION   386

15.3.2      MARKET OVERVIEW       386

15.4         PLANT GROWTH REGULATORS MARKET              387

15.4.1      MARKET DEFINITION   387

15.4.2      MARKET OVERVIEW       387

16            APPENDIX           389

16.1         DISCUSSION GUIDE        389

16.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                393

16.3         CUSTOMIZATION OPTIONS        395

16.4         RELATED REPORTS         395

16.5         AUTHOR DETAILS           396

LIST OF TABLES

TABLE 1                AGRICULTURAL BIOLOGICALS MARKET: INCLUSIONS AND EXCLUSIONS 34

TABLE 2                USD EXCHANGE RATES CONSIDERED, 2020–2024                 36

TABLE 3                AGRICULTURAL BIOLOGICALS MARKET SNAPSHOT, 2025 VS. 2030              48

TABLE 4                US ADJUSTED RECIPROCAL TARIFF RATES                 78

TABLE 5                EXPORT VALUE OF HS CODE 3808, BY KEY COUNTRY,

2020–2024 (USD THOUSAND)      82

TABLE 6                IMPORT VALUE OF HS CODE 3808, BY KEY COUNTRY,

2020–2024 (USD THOUSAND)      84

TABLE 7                AVERAGE SELLING PRICE OF AGRICULTURAL BIOLOGICAL TYPES, BY KEY PLAYER, 2024 (USD/KG)      86

TABLE 8                AVERAGE SELLING PRICE TREND OF AGRICULTURAL BIOLOGICALS, BY TYPE, 2020–2024 (USD/KG)                 87

TABLE 9                AVERAGE SELLING PRICE TREND OF AGRICULTURAL BIOLOGICAL PRODUCTS,

BY REGION, 2020–2024 (USD/KG)               88

TABLE 10              ROLE OF COMPANIES IN ECOSYSTEM    90

TABLE 11              KEY PATENTS PERTAINING TO AGRICULTURAL BIOLOGICALS, 2016–2025               93

TABLE 12              AGRICULTURAL BIOLOGICALS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025–2026                 96

TABLE 13              NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             97

TABLE 14              EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 97

TABLE 15              ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 98

TABLE 16              IMPACT OF PORTER’S FIVE FORCES ON AGRICULTURAL BIOLOGICALS MARKET               107

TABLE 17              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AGRICULTURAL BIOLOGICAL TYPES        110

TABLE 18              KEY BUYING CRITERIA FOR AGRICULTURAL BIOLOGICAL TYPES        111

TABLE 19              AGRICULTURAL BIOLOGICALS MARKET, BY TYPE, 2020–2024 (USD MILLION)                116

TABLE 20              AGRICULTURAL BIOLOGICALS MARKET, BY TYPE, 2025–2030 (USD MILLION)                117

TABLE 21              AGRICULTURAL BIOLOGICALS MARKET, BY TYPE, 2020–2024 (KT)      117

TABLE 22              AGRICULTURAL BIOLOGICALS MARKET, BY TYPE, 2025–2030 (KT)      117

TABLE 23              LIST OF BIOLOGICAL CONTROL AGENTS                 118

TABLE 24              APPROACHES OF BIOCONTROL                119

TABLE 25              BIOCONTROL: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            120

TABLE 26              BIOCONTROL: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            120

TABLE 27              BIOCONTROL: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (USD MILLION)            121

TABLE 28              BIOCONTROL: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (USD MILLION)            121

TABLE 29              BIOCONTROL: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (KT)   121

TABLE 30              BIOCONTROL: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (KT)   122

TABLE 31              BIOFERTILIZERS: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            123

TABLE 32              BIOFERTILIZERS: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            123

TABLE 33              BIOFERTILIZERS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (USD MILLION)            124

TABLE 34              BIOFERTILIZERS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (USD MILLION)            124

TABLE 35              BIOFERTILIZERS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (KT) 124

TABLE 36              BIOFERTILIZERS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (KT)   125

TABLE 37              MAJOR SOURCES OF BIOSTIMULANTS  127

TABLE 38              BIOSTIMULANTS: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            127

TABLE 39              BIOSTIMULANTS: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            127

TABLE 40              BIOSTIMULANTS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (USD MILLION)            128

TABLE 41              BIOSTIMULANTS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (USD MILLION)            128

TABLE 42              BIOSTIMULANTS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (KT)   128

TABLE 43              BIOSTIMULANTS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (KT)   129

TABLE 44              AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE, 2020–2024 (USD MILLION)         133

TABLE 45              AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE, 2025–2030 (USD MILLION)         133

TABLE 46              MICROBIALS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (USD MILLION)            135

TABLE 47              MICROBIALS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (USD MILLION)            135

TABLE 48              MICROBIALS: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE

2020–2024 (USD MILLION)            135

TABLE 49              MICROBIALS: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)          136

TABLE 50              NATURAL PRODUCTS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (USD MILLION)            137

TABLE 51              NATURAL PRODUCTS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (USD MILLION)            137

TABLE 52              NATURAL PRODUCTS: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            138

TABLE 53              NATURAL PRODUCTS: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            138

TABLE 54              MACROBIALS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (USD MILLION)            139

TABLE 55              MACROBIALS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (USD MILLION)            140

TABLE 56              SEMIOCHEMICALS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (USD MILLION)            141

TABLE 57              SEMIOCHEMICALS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (USD MILLION)            141

TABLE 58              SEMIOCHEMICALS: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            142

TABLE 59              SEMIOCHEMICALS: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            142

TABLE 60              AGRICULTURAL BIOLOGICALS MARKET, BY FORMULATION,

2020–2024 (USD MILLION)            145

TABLE 61              AGRICULTURAL BIOLOGICALS MARKET, BY FORMULATION,

2025–2030 (USD MILLION)            145

TABLE 62              LIQUID: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (USD MILLION)            146

TABLE 63              LIQUID: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (USD MILLION)            146

TABLE 64              DRY: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (USD MILLION)            147

TABLE 65              DRY: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (USD MILLION)            147

TABLE 66              AGRICULTURAL BIOLOGICALS MARKET, BY MODE OF APPLICATION,

2020–2024 (USD MILLION)            150

TABLE 67              AGRICULTURAL BIOLOGICALS MARKET, BY MODE OF APPLICATION,

2025–2030 (USD MILLION)            150

TABLE 68              FOLIAR SPRAY: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (USD MILLION)            151

TABLE 69              FOLIAR SPRAY: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (USD MILLION)            151

TABLE 70              SEED TREATMENT: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (USD MILLION)            152

TABLE 71              SEED TREATMENT: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (USD MILLION)            153

TABLE 72              SOIL TREATMENT: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (USD MILLION)            154

TABLE 73              SOIL TREATMENT: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (USD MILLION)            154

TABLE 74              OTHER MODES OF APPLICATION: AGRICULTURAL BIOLOGICALS MARKET,

BY REGION, 2020–2024 (USD MILLION)   155

TABLE 75              OTHER MODES OF APPLICATION: AGRICULTURAL BIOLOGICALS MARKET,

BY REGION, 2025–2030 (USD MILLION)   155

TABLE 76              AGRICULTURAL BIOLOGICALS MARKET, BY CROP TYPE,

2020–2024 (USD MILLION)            157

TABLE 77              AGRICULTURAL BIOLOGICALS MARKET, BY CROP TYPE,

2025–2030 (USD MILLION)            158

TABLE 78              COMMON PLANT DISEASES IN WHEAT 158

TABLE 79              CEREALS & GRAINS: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            159

TABLE 80              CEREALS & GRAINS: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            159

TABLE 81              CEREALS & GRAINS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (USD MILLION)            159

TABLE 82              CEREALS & GRAINS: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (USD MILLION)            160

TABLE 83              OILSEEDS & PULSES: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            162

TABLE 84              OILSEEDS & PULSES: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            162

TABLE 85              OILSEEDS & PULSES: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (USD MILLION)            162

TABLE 86              OILSEEDS & PULSES: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (USD MILLION)            163

TABLE 87              MAJOR CROPS AFFECTED BY ROOT-KNOT NEMATODES     165

TABLE 88              FRUITS & VEGETABLES: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            165

TABLE 89              FRUITS & VEGETABLES: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            166

TABLE 90              FRUITS & VEGETABLES: AGRICULTURAL BIOLOGICALS MARKET, BY REGION, 2020–2024 (USD MILLION)                 166

TABLE 91              FRUITS & VEGETABLES: AGRICULTURAL BIOLOGICALS MARKET, BY REGION, 2025–2030 (USD MILLION)                 166

TABLE 92              OTHER CROP TYPES: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (USD MILLION)            169

TABLE 93              OTHER CROP TYPES: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (USD MILLION)            170

TABLE 94              AGRICULTURAL BIOLOGICALS MARKET, BY REGION, 2020–2024 (USD MILLION)          173

TABLE 95              AGRICULTURAL BIOLOGICALS MARKET, BY REGION, 2025–2030 (USD MILLION)          174

TABLE 96              AGRICULTURAL BIOLOGICALS MARKET, BY REGION, 2020–2024 (KT)                 174

TABLE 97              AGRICULTURAL BIOLOGICALS MARKET, BY REGION, 2025–2030 (KT)                 174

TABLE 98              NORTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY COUNTRY,

2020–2024 (USD MILLION)            176

TABLE 99              NORTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY COUNTRY,

2025–2030 (USD MILLION)            177

TABLE 100            NORTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            177

TABLE 101            NORTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            177

TABLE 102            NORTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (KT)   178

TABLE 103            NORTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (KT)   178

TABLE 104            NORTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE,

2020–2024 (USD MILLION)            178

TABLE 105            NORTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE,

2025–2030 (USD MILLION)            179

TABLE 106            NORTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET,

BY MODE OF APPLICATION, 2020–2024 (USD MILLION)  179

TABLE 107            NORTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET,

BY MODE OF APPLICATION, 2025–2030 (USD MILLION)  179

TABLE 108            NORTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY CROP TYPE,

2020–2024 (USD MILLION)            180

TABLE 109            NORTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY CROP TYPE,

2025–2030 (USD MILLION)            180

TABLE 110            NORTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY FORMULATION, 2020–2024 (USD MILLION)            180

TABLE 111            NORTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY FORMULATION, 2025–2030 (USD MILLION)            181

TABLE 112            US: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE, 2020–2024 (USD MILLION)                182

TABLE 113            US: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE, 2025–2030 (USD MILLION)                182

TABLE 114            CROPS INFESTED BY INSECT PESTS IN CANADA                 183

TABLE 115            CANADA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            184

TABLE 116            CANADA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            184

TABLE 117            MEXICO: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            185

TABLE 118            MEXICO: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            186

TABLE 119            EUROPE: AGRICULTURAL BIOLOGICALS MARKET, BY COUNTRY,

2020–2024 (USD MILLION)            187

TABLE 120            EUROPE: AGRICULTURAL BIOLOGICALS MARKET, BY COUNTRY,

2025–2030 (USD MILLION)            188

TABLE 121            EUROPE: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            188

TABLE 122            EUROPE: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            188

TABLE 123            EUROPE: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE, 2020–2024 (KT)            189

TABLE 124            EUROPE: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE, 2025–2030 (KT)            189

TABLE 125            EUROPE: AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE,

2020–2024 (USD MILLION)            189

TABLE 126            EUROPE: AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE,

2025–2030 (USD MILLION)            190

TABLE 127            EUROPE: AGRICULTURAL BIOLOGICALS MARKET, BY MODE OF APPLICATION, 2020–2024 (USD MILLION)                 190

TABLE 128            EUROPE: AGRICULTURAL BIOLOGICALS MARKET, BY MODE OF APPLICATION, 2025–2030 (USD MILLION)                 190

TABLE 129            EUROPE: AGRICULTURAL BIOLOGICALS MARKET, BY CROP TYPE,

2020–2024 (USD MILLION)            191

TABLE 130            EUROPE: AGRICULTURAL BIOLOGICALS MARKET, BY CROP TYPE,

2025–2030 (USD MILLION)            191

TABLE 131            EUROPE: AGRICULTURAL BIOLOGICALS MARKET, BY FORMULATION, 2020–2024 191

TABLE 132            EUROPE: AGRICULTURAL BIOLOGICALS MARKET, BY FORMULATION, 2025–2030 191

TABLE 133            GERMANY: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            193

TABLE 134            GERMANY: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            193

TABLE 135            FRANCE: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            194

TABLE 136            FRANCE: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            194

TABLE 137            VARIOUS CITRUS DISEASES CAUSED BY PATHOGENS      195

TABLE 138            SPAIN: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            196

TABLE 139            SPAIN: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            196

TABLE 140            ITALY: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            197

TABLE 141            ITALY: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            197

TABLE 142            UK: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE, 2020–2024 (USD MILLION)                198

TABLE 143            UK: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE, 2025–2030 (USD MILLION)                198

TABLE 144            REST OF EUROPE: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            199

TABLE 145            REST OF EUROPE: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            200

TABLE 146            ASIA PACIFIC: AGRICULTURAL BIOLOGICALS MARKET, BY COUNTRY,

2020–2024 (USD MILLION)            201

TABLE 147            ASIA PACIFIC: AGRICULTURAL BIOLOGICALS MARKET, BY COUNTRY,

2025–2030 (USD MILLION)            201

TABLE 148            ASIA PACIFIC: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            201

TABLE 149            ASIA PACIFIC: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            202

TABLE 150            ASIA PACIFIC: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE, 2020–2024 (KT)            202

TABLE 151            ASIA PACIFIC: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE, 2025–2030 (KT)            202

TABLE 152            ASIA PACIFIC: AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE,

2020–2024 (USD MILLION)            203

TABLE 153            ASIA PACIFIC: AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE,

2025–2030 (USD MILLION)            203

TABLE 154            ASIA PACIFIC: AGRICULTURAL BIOLOGICALS MARKET, BY MODE OF APPLICATION, 2020–2024 (USD MILLION)                 203

TABLE 155            ASIA PACIFIC: AGRICULTURAL BIOLOGICALS MARKET, BY MODE OF APPLICATION, 2025–2030 (USD MILLION)                 204

TABLE 156            ASIA PACIFIC: AGRICULTURAL BIOLOGICALS MARKET, BY CROP TYPE,

2020–2024 (USD MILLION)            204

TABLE 157            ASIA PACIFIC: AGRICULTURAL BIOLOGICALS MARKET, BY CROP TYPE,

2025–2030 (USD MILLION)            204

TABLE 158            ASIA PACIFIC: AGRICULTURAL BIOLOGICALS MARKET, BY FORMULATION,

2020–2024 (USD MILLION)            205

TABLE 159            ASIA PACIFIC: AGRICULTURAL BIOLOGICALS MARKET, BY FORMULATION,

2025–2030 (USD MILLION)            205

TABLE 160          CHINA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            206

TABLE 161          CHINA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            206

TABLE 162          JAPAN: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            207

TABLE 163          JAPAN: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            208

TABLE 164            PESTICIDES BANNED FOR MANUFACTURE, IMPORT, AND USE IN INDIA        209

TABLE 165            PESTICIDE FORMULATIONS BANNED FOR IMPORT,

MANUFACTURE, AND USE IN INDIA        209

TABLE 166            PESTICIDE/PESTICIDE FORMULATIONS BANNED FOR USE

BUT CONTINUED TO BE MANUFACTURED FOR EXPORT IN INDIA    210

TABLE 167            LIST OF BIOCONTROLS USED AGAINST MAJOR PESTS IN INDIA 210

TABLE 168            INDIA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            210

TABLE 169            INDIA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            210

TABLE 170            AUSTRALIA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            211

TABLE 171            AUSTRALIA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            212

TABLE 172            REST OF ASIA PACIFIC: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            213

TABLE 173            REST OF ASIA PACIFIC: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            213

TABLE 174            SOUTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY COUNTRY,

2020–2024 (USD MILLION)            214

TABLE 175            SOUTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY COUNTRY,

2025–2030 (USD MILLION)            214

TABLE 176            SOUTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            215

TABLE 177            SOUTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            215

TABLE 178            SOUTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (KT)   215

TABLE 179            SOUTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (KT)   215

TABLE 180            SOUTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE,

2020–2024 (USD MILLION)            216

TABLE 181            SOUTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE,

2025–2030 (USD MILLION)            216

TABLE 182            SOUTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET,

BY MODE OF APPLICATION, 2020–2024 (USD MILLION)  216

TABLE 183            SOUTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET,

BY MODE OF APPLICATION, 2025–2030 (USD MILLION)  217

TABLE 184            SOUTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY CROP TYPE,

2020–2024 (USD MILLION)            217

TABLE 185            SOUTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY CROP TYPE,

2025–2030 (USD MILLION)            217

TABLE 186            SOUTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY FORMULATION, 2020–2024 (USD MILLION)            218

TABLE 187            SOUTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY FORMULATION, 2025–2030 (USD MILLION)            218

TABLE 188            BRAZIL: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            219

TABLE 189            BRAZIL: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            219

TABLE 190            ARGENTINA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            220

TABLE 191            ARGENTINA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE

2025–2030 (USD MILLION)            221

TABLE 192            REST OF SOUTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE, 2020–2024 (USD MILLION)                 222

TABLE 193            REST OF SOUTH AMERICA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE, 2025–2030 (USD MILLION)                 222

TABLE 194            REST OF THE WORLD: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2020–2024 (USD MILLION)            223

TABLE 195            REST OF THE WORLD: AGRICULTURAL BIOLOGICALS MARKET, BY REGION,

2025–2030 (USD MILLION)            223

TABLE 196            REST OF THE WORLD: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            224

TABLE 197            REST OF THE WORLD: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            224

TABLE 198            REST OF THE WORLD: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (KT)   224

TABLE 199            REST OF THE WORLD: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (KT)   224

TABLE 200            REST OF THE WORLD: AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE,

2020–2024 (USD MILLION)            225

TABLE 201            REST OF THE WORLD: AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE,

2025–2030 (USD MILLION)            225

TABLE 202            REST OF THE WORLD: AGRICULTURAL BIOLOGICALS MARKET,

BY MODE OF APPLICATION, 2020–2024 (USD MILLION)  225

TABLE 203            REST OF THE WORLD: AGRICULTURAL BIOLOGICALS MARKET,

BY MODE OF APPLICATION, 2025–2030 (USD MILLION)  226

TABLE 204            REST OF THE WORLD: AGRICULTURAL BIOLOGICALS MARKET,

BY CROP TYPE, 2020–2024 (USD MILLION)            226

TABLE 205            REST OF THE WORLD: AGRICULTURAL BIOLOGICALS MARKET,

BY CROP TYPE, 2025–2030 (USD MILLION)            226

TABLE 206            REST OF THE WORLD: AGRICULTURAL BIOLOGICALS MARKET, BY FORMULATION, 2020–2024 (USD MILLION)            227

TABLE 207            REST OF THE WORLD: AGRICULTURAL BIOLOGICALS MARKET, FORMULATION, 2025–2030 (USD MILLION)            227

TABLE 208            AFRICA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            228

TABLE 209            AFRICA: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            228

TABLE 210            MIDDLE EAST: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2020–2024 (USD MILLION)            229

TABLE 211            MIDDLE EAST: AGRICULTURAL BIOLOGICALS MARKET, BY TYPE,

2025–2030 (USD MILLION)            230

TABLE 212            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AGRICULTURAL BIOLOGICALS MARKET, 2020–2025                 232

TABLE 213            AGRICULTURAL BIOLOGICALS MARKET: DEGREE OF COMPETITION         236

TABLE 214            AGRICULTURAL BIOLOGICALS MARKET: REGION FOOTPRINT     241

TABLE 215            AGRICULTURAL BIOLOGICALS MARKET: TYPE FOOTPRINT       242

TABLE 216            AGRICULTURAL BIOLOGICALS MARKET: SOURCE FOOTPRINT     243

TABLE 217            AGRICULTURAL BIOLOGICALS MARKET: FORMULATION FOOTPRINT      243

TABLE 218            AGRICULTURAL BIOLOGICALS MARKET: KEY STARTUPS/SMES              246

TABLE 219            AGRICULTURAL BIOLOGICALS MARKET: COMPETITIVE BENCHMARKING OF

KEY STARTUPS/SMES, 2024          247

TABLE 220            AGRICULTURAL BIOLOGICALS MARKET: PRODUCT LAUNCHES,

2020–SEPTEMBER 2025   250

TABLE 221          AGRICULTURAL BIOLOGICALS MARKET: DEALS, 2020– SEPTEMBER 2025  258

TABLE 222            AGRICULTURAL BIOLOGICALS MARKET: EXPANSIONS, 2020–SEPTEMBER 2025       270

TABLE 223            BASF SE: COMPANY OVERVIEW 274

TABLE 224            BASF SE: PRODUCTS OFFERED  275

TABLE 225            BASF SE: PRODUCT LAUNCHES AND APPROVALS        277

TABLE 226            BASF SE: DEALS 277

TABLE 227            BASF SE: EXPANSIONS   280

TABLE 228            SYNGENTA: COMPANY OVERVIEW          282

TABLE 229            SYNGENTA: PRODUCTS OFFERED           283

TABLE 230            SYNGENTA: PRODUCT LAUNCHES AND APPROVALS        287

TABLE 231            SYNGENTA: DEALS          288

TABLE 232            SYNGENTA: EXPANSIONS             293

TABLE 233            FMC CORPORATION: COMPANY OVERVIEW                 296

TABLE 234            FMC CORPORATION: PRODUCTS OFFERED                 297

TABLE 235            FMC CORPORATION: PRODUCT LAUNCHES AND APPROVALS             298

TABLE 236            FMC CORPORATION: DEALS       299

TABLE 237            FMC CORPORATION: OTHER DEVELOPMENTS                 301

TABLE 238            UPL: COMPANY OVERVIEW         302

TABLE 239            UPL: PRODUCTS OFFERED          303

TABLE 240            UPL: PRODUCT LAUNCHES AND APPROVALS                 305

TABLE 241            UPL: DEALS        307

TABLE 242            BAYER AG: COMPANY OVERVIEW             309

TABLE 243            BAYER AG: PRODUCTS OFFERED              310

TABLE 244            BAYER AG: PRODUCT LAUNCHES AND APPROVALS        311

TABLE 245            BAYER AG: DEALS            312

TABLE 246            BAYER AG: EXPANSIONS               314

TABLE 247            CORTEVA: COMPANY OVERVIEW             316

TABLE 248            CORTEVA: PRODUCTS OFFERED              317

TABLE 249            CORTEVA: PRODUCT LAUNCHES AND APPROVALS        318

TABLE 250            CORTEVA: DEALS            319

TABLE 251            BIOFIRST GROUP: COMPANY OVERVIEW                 325

TABLE 252            BIOFIRST GROUP: PRODUCTS OFFERED                 325

TABLE 253            BIOFIRST GROUP: PRODUCT LAUNCHES AND APPROVALS        326

TABLE 254            BIOFIRST GROUP: DEALS             327

TABLE 255            BIOFIRST GROUP: EXPANSIONS                329

TABLE 256            LALLEMAND INC.: COMPANY OVERVIEW                 330

TABLE 257            LALLEMAND INC: PRODUCTS OFFERED                 331

TABLE 258            LALLEMAND: PRODUCT LAUNCHES AND APPROVALS        332

TABLE 259            NUFARM: COMPANY OVERVIEW               333

TABLE 260            NUFARM: PRODUCTS OFFERED                334

TABLE 261            NUFARM: PRODUCT LAUNCHES AND APPROVALS        335

TABLE 262            NUFARM: DEALS               336

TABLE 263            NUFARM: OTHER DEVELOPMENTS         336

TABLE 264            MOSAIC: COMPANY OVERVIEW 337

TABLE 265            MOSAIC: PRODUCTS OFFERED 338

TABLE 266            MOSAIC: PRODUCT LAUNCHES AND APPROVALS        339

TABLE 267            MOSAIC: DEALS                339

TABLE 268            SUMITOMO CHEMICAL CO., LTD.: COMPANY OVERVIEW          341

TABLE 269            SUMITOMO CHEMICAL CO., LTD.: PRODUCTS OFFERED             342

TABLE 270            SUMITOMO CHEMICAL CO., LTD.: PRODUCT LAUNCHES AND APPROVALS     344

TABLE 271            SUMITOMO CHEMICAL CO., LTD.: DEALS                 344

TABLE 272            SUMITOMO CHEMICAL CO., LTD.: EXPANSIONS                 345

TABLE 273            INDIGO AG, INC.: COMPANY OVERVIEW                 347

TABLE 274            INDIGO AG, INC.: PRODUCTS OFFERED                 347

TABLE 275            INDIGO AG, INC.: PRODUCT LAUNCHES AND APPROVALS        348

TABLE 276            INDIGO AG, INC.: DEALS               348

TABLE 277            NOVONESIS GROUP: COMPANY OVERVIEW                 349

TABLE 278            NOVONESIS GROUP: PRODUCTS OFFERED                 350

TABLE 279            NOVONESIS: PRODUCT LAUNCHES AND APPROVALS        351

TABLE 280            NOVONESIS GROUP: DEALS        352

TABLE 281            BIOCERES CROP SOLUTIONS: COMPANY OVERVIEW          354

TABLE 282            BIOCERES CROP SOLUTIONS: PRODUCTS OFFERED             355

TABLE 283            BIOCERES CROP SOLUTIONS: PRODUCT LAUNCHES AND APPROVALS     356

TABLE 284            BIOCERES CROP SOLUTIONS: DEALS     357

TABLE 285            KOPPERT: COMPANY OVERVIEW             359

TABLE 286            KOPPERT: PRODUCTS OFFERED              359

TABLE 287            KOPPERT: PRODUCT LAUNCHES AND APPROVALS        360

TABLE 288            KOPPERT: DEALS             361

TABLE 289            KOPPERT: EXPANSIONS                364

TABLE 290            ROVENSA NEXT: COMPANY OVERVIEW 365

TABLE 291            ROVENSA NEXT: PRODUCTS OFFERED 365

TABLE 292            ROVENSA NEXT: PRODUCT LAUNCHES AND APPROVALS        366

TABLE 293            ROVENSA NEXT: DEALS                 367

TABLE 294            ROVENSA NEXT: EXPANSIONS   367

TABLE 295            MERISTEM CROP PERFORMANCE GROUP LLC: COMPANY OVERVIEW   368

TABLE 296            MERISTEM CROP PERFORMANCE GROUP LLC: PRODUCTS OFFERED    368

TABLE 297            SUSTAINABLE AGRO SOLUTIONS, S.A.U.: COMPANY OVERVIEW   369

TABLE 298            SUSTAINABLE AGRO SOLUTIONS, S.A.U.: PRODUCTS OFFERED    369

TABLE 299            SUSTAINABLE AGRO SOLUTIONS, S.A.U.: DEALS                 371

TABLE 300            CERTIS USA L.L.C.: COMPANY OVERVIEW                 372

TABLE 301            CERTIS USA L.L.C.: PRODUCTS OFFERED                 372

TABLE 302            CERTIS USA L.L.C.: PRODUCT LAUNCHES AND APPROVALS        374

TABLE 303            CERTIS USA L.L.C.: DEALS            375

TABLE 304            CERTIS USA L.L.C.: OTHER DEVELOPMENTS                 376

TABLE 305            BIONEMA: COMPANY OVERVIEW             377

TABLE 306            BIONEMA: PRODUCTS OFFERED              377

TABLE 307            BIONEMA: PRODUCT LAUNCHES AND APPROVALS        378

TABLE 308            BIONEMA: DEALS             379

TABLE 309            ANDERMATT BIOCONTROL AG: BUSINESS OVERVIEW          380

TABLE 310            BIOCONSORTIA: COMPANY OVERVIEW 381

TABLE 311            APHEA.BIO: COMPANY OVERVIEW          382

TABLE 312            GÊNICA: COMPANY OVERVIEW 383

TABLE 313            NORDIC MICROBES A/S: COMPANY OVERVIEW                 384

TABLE 314            ADJACENT MARKETS TO AGRICULTURAL BIOLOGICALS   385

TABLE 315            BIOPESTICIDES MARKET, BY TYPE, 2019–2023 (USD MILLION) 386

TABLE 316            BIOPESTICIDES MARKET, BY TYPE, 2024–2029 (USD MILLION) 386

TABLE 317            BIOPESTICIDES MARKET, BY TYPE, 2019–2023 (KT)       387

TABLE 318            BIOPESTICIDES MARKET, BY TYPE, 2024–2029 (KT)       387

TABLE 319            PLANT GROWTH REGULATORS MARKET, BY TYPE, 2019–2023 (USD MILLION)                388

TABLE 320            PLANT GROWTH REGULATORS MARKET, BY TYPE, 2024–2029 (USD MILLION)                388

LIST OF FIGURES

FIGURE 1              AGRICULTURAL BIOLOGICALS MARKET SEGMENTATION              33

FIGURE 2              RESEARCH DESIGN         38

FIGURE 3              KEY DATA FROM SECONDARY SOURCES                 39

FIGURE 4              KEY DATA FROM PRIMARY SOURCES     40

FIGURE 5              INSIGHTS FROM INDUSTRY EXPERTS     41

FIGURE 6              BREAKDOWN OF PRIMARIES, BY VALUE CHAIN, DESIGNATION, AND REGION     42

FIGURE 7              AGRICULTURAL BIOLOGICALS MARKET: DEMAND-SIDE CALCULATION  43

FIGURE 8              AGRICULTURAL BIOLOGICALS MARKET SIZE ESTIMATION STEPS AND RESPECTIVE SOURCES: SUPPLY SIDE                 44

FIGURE 9              AGRICULTURAL BIOLOGICALS MARKET: SUPPLY-SIDE ANALYSIS                 45

FIGURE 10            DATA TRIANGULATION METHODOLOGY                 46

FIGURE 11            AGRICULTURAL BIOLOGICALS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)         49

FIGURE 12            AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE,

2025 VS. 2030 (USD MILLION)      49

FIGURE 13            AGRICULTURAL BIOLOGICALS MARKET, BY MODE OF APPLICATION,

2025 VS. 2030 (USD MILLION)      50

FIGURE 14            AGRICULTURAL BIOLOGICALS MARKET, BY FORMULATION,

2025 VS. 2030 (USD MILLION)      51

FIGURE 15            AGRICULTURAL BIOLOGICALS MARKET, BY CROP TYPE,

2025 VS. 2030 (USD MILLION)      51

FIGURE 16            AGRICULTURAL BIOLOGICALS MARKET SHARE AND CAGR, BY REGION 52

FIGURE 17            RISING DEMAND FOR SUSTAINABLE AND ECO-FRIENDLY FARMING SOLUTIONS TO DRIVE MARKET     53

FIGURE 18            BIOCONTROL SEGMENT AND US TO ACCOUNT FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2025                 54

FIGURE 19            US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2025 (VALUE)                54

FIGURE 20            BIOCONTROL SEGMENT TO DOMINATE MARKET SHARE DURING FORECAST PERIOD     55

FIGURE 21            MICROBIALS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD       56

FIGURE 22            LIQUID SEGMENT TO LEAD MARKET DURING STUDY PERIOD 57

FIGURE 23            FOLIAR SPRAY SEGMENT TO LEAD MARKET DURING FORECAST PERIOD       58

FIGURE 24            FRUITS & VEGETABLES SEGMENT TO DOMINATE MARKET

DURING FORECAST PERIOD       59

FIGURE 25            US TOTAL FARM EXPENDITURES, 2013–2023 (USD MILLION) 61

FIGURE 26            ORGANIC AGRICULTURAL LAND, BY REGION, 2023        62

FIGURE 27            WORLD POPULATION GROWTH, 1950–2050 (BILLION)            63

FIGURE 28            AGRICULTURAL BIOLOGICALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES                 64

FIGURE 29            TOP 10 COUNTRIES WITH ORGANIC MARKET, 2022–2023              66

FIGURE 30            ADOPTION OF GENERATIVE AI IN AGRICULTURAL BIOLOGICALS PRODUCTION PROCESS                 74

FIGURE 31            AGRICULTURAL BIOLOGICALS MARKET: VALUE CHAIN ANALYSIS               80

FIGURE 32            EXPORT VALUE OF HS CODE 3808: KEY COUNTRIES,

2020–2024 (USD THOUSAND)      82

FIGURE 33            IMPORT VALUE OF HS CODE 3808: KEY COUNTRIES,

2020–2024 (USD THOUSAND)      83

FIGURE 34            AVERAGE SELLING PRICE OF AGRICULTURAL BIOLOGICAL TYPES,

BY KEY PLAYER, 2024      86

FIGURE 35            AVERAGE SELLING PRICE TREND OF AGRICULTURAL BIOLOGICALS, BY TYPE, 2020–2024 (USD/KG)                 87

FIGURE 36            AVERAGE SELLING PRICE TREND OF AGRICULTURAL BIOLOGICAL PRODUCTS,

BY REGION, 2020–2024    88

FIGURE 37            AGRICULTURAL BIOLOGICALS MARKET: ECOSYSTEM ANALYSIS  90

FIGURE 38            AGRICULTURAL BIOLOGICALS MARKET: TRENDS/DISRUPTING IMPACTING CUSTOMER BUSINESS                 91

FIGURE 39            PATENTS APPLIED AND GRANTED FOR AGRICULTURAL BIOLOGICALS MARKET, 2016–2025          92

FIGURE 40            REGIONAL ANALYSIS OF PATENTS GRANTED FOR AGRICULTURAL BIOLOGICALS MARKET, 2016–2025                 93

FIGURE 41            AGRICULTURAL BIOLOGICALS MARKET: PORTER’S FIVE FORCES ANALYSIS           108

FIGURE 42            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AGRICULTURAL BIOLOGICAL TYPES        110

FIGURE 43            KEY BUYING CRITERIA FOR AGRICULTURAL BIOLOGICAL TYPES        111

FIGURE 44            INVESTMENT AND FUNDING SCENARIO OF FEW MAJOR PLAYERS (2010–APRIL 2025)                112

FIGURE 45            AGRICULTURAL BIOLOGICALS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)         116

FIGURE 46            AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE,

2025 VS. 2030 (USD MILLION)      132

FIGURE 47            AGRICULTURAL BIOLOGICALS MARKET, BY FORMULATION,

2025 VS. 2030 (USD MILLION)      144

FIGURE 48            AGRICULTURAL BIOLOGICALS MARKET, BY MODE OF APPLICATION,

2025 VS. 2030 (USD MILLION)      149

FIGURE 49            AGRICULTURAL BIOLOGICALS MARKET, BY CROP TYPE,

2025 VS. 2030 (USD MILLION)      157

FIGURE 50            US TO EXHIBIT HIGHEST GROWTH RATE DURING FORECAST PERIOD       173

FIGURE 51            NORTH AMERICA: MARKET SNAPSHOT 176

FIGURE 52            EUROPE: MARKET SNAPSHOT   187

FIGURE 53            REVENUE ANALYSIS OF KEY MARKET PLAYERS, 2020–2024 (USD BILLION)             234

FIGURE 54            SHARE ANALYSIS OF AGRICULTURAL BIOLOGICALS MARKET, 2024      235

FIGURE 55            AGRICULTURAL BIOLOGICALS MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2024       239

FIGURE 56            AGRICULTURAL BIOLOGICALS MARKET: COMPANY FOOTPRINT 240

FIGURE 57            AGRICULTURAL BIOLOGICALS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024                 245

FIGURE 58            COMPANY VALUATION OF KEY VENDORS                 248

FIGURE 59            EV/EBITDA OF KEY COMPANIES               248

FIGURE 60            COMPARATIVE ANALYSIS COMPANY BRANDS/PRODUCTS      249

FIGURE 61            BASF SE: COMPANY SNAPSHOT 275

FIGURE 62            SYNGENTA: COMPANY SNAPSHOT          283

FIGURE 63            FMC CORPORATION: COMPANY SNAPSHOT                 297

FIGURE 64            UPL: COMPANY SNAPSHOT        303

FIGURE 65            BAYER AG: COMPANY SNAPSHOT            310

FIGURE 66            CORTEVA: COMPANY SNAPSHOT             317

FIGURE 67            NUFARM: COMPANY SNAPSHOT               334

FIGURE 68            MOSAIC: COMPANY SNAPSHOT                 338

FIGURE 69            SUMITOMO CHEMICAL CO., LTD: COMPANY SNAPSHOT          342

FIGURE 70            NOVONESIS GROUP: COMPANY SNAPSHOT                 350

FIGURE 71            BIOCERES CROP SOLUTIONS: COMPANY SNAPSHOT          355